Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can neutralize the virus. It is, however, unknown which features of the serological response may affect clinical outcomes of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Immunol
Main Authors: Röltgen, Katharina, Powell, Abigail E., Wirz, Oliver F., Stevens, Bryan A., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Wang, Hannah, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manohar, Monali, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Narasimhan, Balasubramanian, Gombar, Saurabh, Tibshirani, Robert, Nadeau, Kari C., Kim, Peter S., Pinsky, Benjamin A., Boyd, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Association for the Advancement of Science 2020
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7857392/
https://ncbi.nlm.nih.gov/pubmed/33288645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.abe0240
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados